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Objective: To describe the cross-sectional and longitudinal association between hip Bone marrow lesions
(BMLs) and bone density.
Design: 198 subjects with a right hip MRI and dual-energy X-ray absorptiometry (DXA) scans conducted
at two time points, approximately 2.6 years apart were included. MR images were used to assess hip BML
presence and size (cm2) while DXA scans were used to determine bone mineral density (BMD) of the
total hip, spine and femoral neck.
Results: Fifty-ﬁve subjects (28%) had either a femoral and/or acetabular BML. Cross-sectionally, acetabular
BMLs were associated with 5e6% lower total hip [P ¼ 0.01] and femoral neck BMD [P < 0.001]. Resolving
acetabular BMLs were associated with a 1e2% increase in BMD at hip [P ¼ 0.05] and femoral neck
[P ¼ 0.01]. In contrast, resolving femoral BMLs were associated with a 4% lower and incident femoral
BMLs with 3% higher femoral neck BMD [P ¼ 0.04, P < 0.001 resp.]. Finally, each 1 cm2 change femoral
BMLs was associated with increase in femoral neck BMD: þ0.03 g/cm2, 95% conﬁdence intervals
(CI): þ0.00, þ0.05, and enlarging acetabular BMLs was associated with decrease in hip: 0.01 g/cm2, 95%
CI: 0.03, 0.00 and femoral neck BMD: 0.01 g/cm2, 95% CI: 0.03, 0.001.
Conclusion: Hip BMLs were associated with local BMD (hip and femoral neck) but not with spine BMD
and these associations vary according to site. BML prevalence and change was low in this study, hence
these ﬁndings need conﬁrmation. However, we hypothesize that these associations represent a combi-
nation of changes related directly to the BML pathology or changes adjacent to the disease process.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Bone marrow lesions (BMLs) are a key feature of osteoarthritis
(OA) and are associated with pain1, cartilage defects, cartilage vol-
ume loss2 and joint replacement1. Similarly, BMLs of the hip are
associated with hip pain and hip joint space narrowing3.
Bone density is usually higher in subjects with OA4 and its
relationship with knee BMLs has been explored. Lo et al. docu-
mented an increased ratio of compartment speciﬁc local tibial bone
mineral density (BMD) in association with knee BMLs5. We found a
positive correlation between knee BMLs and subchondral bone
density in a community based sample6. Furthermore, Hunter et al.,
demonstrated an increased bone volume fraction but a decrease in
tissue mineral density in cores of bone area affected by knee BMLsH. Ahedi, Menzies Research
g 23, Hobart, Tasmania 7000,
edi).
s Research Society International. Pin women awaiting knee replacement7. The increase in bone den-
sity may be due to ongoing remodeling of damaged trabeculae in
areas where BMLs were located5.
Studies looking into the association between BMLs and bone
density in joints other than the knee are limited8. Similar changes
in bone density are seen in subjects with hip OA4, however the
association between hip BMLs and BMD is yet to be examined.
Hence, the aims of this study were to describe the cross-sectional
and longitudinal relationship between hip BMLs and total hip,
femoral neck and spine BMD.
Materials and methods
Subjects
The Tasmanian Older Adult Cohort (TASOAC) study is a
population-based cohort and the study design has been extensively
described in previous manuscripts1,2,6. The hip protocol was added
during the latter part of phase 2. In the current study a sample of 245ublished by Elsevier Ltd. All rights reserved.
Participants enrolled in TASOAC at Phase 1. 
N= 1100
Attended Phase 1 clinic (n=1099) 
Subjects with a hip MRI scan (T1) at Phase 1 (n=152) and DXA scan (n=1094) 
Subjects with a hip MRI scan (STIR sequence) at Phase 2 (n=228) and DXA scan (n=872)
Subjects with a hip MRI scan (STIR sequence) at Phase 3 (n=215) and DXA scan (n=761)
No subjects from Phase 1 were 
included in the current study, as 
they had no hip MRI STIR 
sequence.
Phase 2: 2.6 years follow-up (n=875)
Phase 3: 5 years follow-up (n=769), 2.3 years from Phase 2
Hip MRIs (STIR sequence) were 
introduced during the latter part of 
Phase 2
Subjects lost to follow up or 
missing STIR sequence. 
Phase 2 (n= 17): Missing STIR 
sequence.
Phase 3 (n=30): Lost to follow-
up.
Subjects with a hip STIR MRI and DEXA scan at both Phase 2 and Phase 3 (n= 198).
Fig. 1. Sample population inclusion chart.
Fig. 2. Measurement of femoral BML.
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MRI sequence at phase 2 and/or phase 3 were included (Fig. 1). Of
these 245 participants, 30 participants were lost to follow-up at
phase 3 and 17 participants had missing STIR sequences at phase 2
hence the totalnumberofparticipantswhohadahipSTIRMRIscanat
both phases was 198. This study was approved by the Southern
Tasmanian Health and Medical Human Research Ethics Committee
and written informed consent was obtained.
Clinical and dual-energy X-ray absorptiometry (DXA) measurements
Height, weight and BMI were measured using standard pro-
tocols. BMD of the hip, femoral neck and spine at both phase 2 and
phase 3 was assessed by DXA using a Hologic Delphi scanner as
previously described6.
Magnetic resonance imaging
The right hip was imaged in the sagittal plane using a 1.5 T G.E
signal whole-body magnetic resonance unit with a phased-array
ﬂex coil. The following image sequence was used: STIR-weighted
fat saturation two-dimensional fast spin echo sequence; repeti-
tion time 4340 msec, echo time 28.4 msec; ﬁeld of view 20 cm; 15
partitions and 512  512 pixel matrix. Sagittal images were ob-
tained at slice thickness of 3.5 mmwith an interslice gap of 1.5 mm.
Measurement of hip BMLs
For quantitative assessment of subchondral hip BMLs Osiri X
software (University of Geneva, Geneva, Switzerland) was used. Hip
BMLs were identiﬁed as areas of increased signal intensity adjacent
to the subchondral bone on the femoral head and/or the acetabu-
lum. One trained observer manually selected the MR slice with the
largest BML and then scored the maximum area (cm2) of all the
identiﬁed lesions bymanually drawing contours around their outeredges (Fig. 2). The BML with the highest score was used if more
than one lesion was present at the same site. Intra-observer
repeatability was assessed and the intra-class correlation coefﬁ-
cient (ICC) of the hip, femoral and acetabular BMLs was 0.98, 0.96
and 0.99 respectively (n ¼ 25), similar to the reproducibility of our
knee quantitative BML measure1.
Statistical analysis
Student’s t tests and chi-squared tests were applied to deter-
mine the differences in means and proportions. The ﬁt of all models
were tested and all assumptions were fulﬁlled. Cross-sectional and
longitudinal analyses were based on linear regression. Cross-
sectionally, the relationship between hip BML presence or
absence and BMD of the hip, femoral neck and spine was estimated
by determining the mean difference in BMD of subjects with and
H. Ahedi et al. / Osteoarthritis and Cartilage 21 (2013) 1545e1549 1547without hip BMLs. These analyses were adjusted for age, sex, BMI
and presence or absence of radiological hip OA (ROA), as adding
covariates for these factors to the models changed the estimated
coefﬁcient of the study factor (BMLs) by more than 10%. For all
cross-sectional analyses, data on subjects at phase 2 and phase 3
was combined and the correlation between repeated measure-
ments on individuals was taken into account by adjusting standard
errors using the sandwich (robust) estimator of variance
(Supplemantary References 1e4). Lastly, the relationship between
change in BML size and change in BMD of the hip, femoral neck and
spine from baseline to follow-up for subjects with a BML at either
time point was analyzed. All models were adjusted for age, sex and
body mass index. All statistical tests were two sided and P values
<0.05 were considered signiﬁcant.Results
Of the 198 subjects, 28% (N ¼ 55) had a hip BML. Subjects with
and without BMLs were similar in gender distribution (62% vs 54%
male), mean age 64 years for both and mean [standard deviations
(SD)] BMI [27.2 (4.40) vs 27.8 (4.61)]. BMD at the hip, spine and
femoral neck was lower in subjects with any hip BML and the dif-
ference at the femoral neck [P ¼ 0.03] was statistically signiﬁcant.
Lastly, acetabular BMLs [mean (SD): 0.74 (0.55)] were larger in
comparison to femoral BMLs [mean (SD): 0.15 (0.41)].
Table I shows the cross-sectional relationship between hip BML
presence and BMD at the hip, femoral neck and spine. The presence
of acetabular BMLs was associated with lower BMD at the hip and
femoral neck. Further, these associations persisted after adjustment
for radiographic hip OA. BML size was not signiﬁcantly associated
with BMD but subjects with femoral BMLs had 12% lower femoral
neck BMD as the difference in BMD per unit increase in femoral
BML was 0.12 (95% CI 0.24, þ0.01).
Table II presents the association between incident and resolving
hip BMLs and change in BMD. Resolving femoral BMLs were asso-
ciated with a decrease while incident femoral BMLs were associ-
ated with an increase in femoral neck BMD. Conversely, resolving
acetabular BMLs were associated with an increase in hip and
femoral neck BMD while incident acetabular BMLs were not asso-
ciated with BMD at any site. Persistent hip BMLs were not associ-
ated with changes in bone density.
Lastly each 1 cm2 change in acetabular BML size was associated
with a decrease in total hip and femoral neck BMD: 0.01, 95%
CI: 0.03, 0.004 and 0.01, 95% CI: 0.03, 0.001 respectively.
Whereas per 1 cm2 increase in femoral BML size was positively
associated with increase in femoral neck BMD: þ0.03, 95%
CI: þ0.00, þ0.05.Table I
Cross-sectional relationship between presence of hip BMLs and bone density at the hip,
BML category Total hip BMD (g/cm2) Femoral neck BM
N* Mean (SD) Adjusted mean
difference (95% CI)y
N* Mean (
Femoral BML
No BML 412 0.97 (0.14) 412 0.77 (0.
BML present 15 0.99 (0.13) þ0.01 (0.07, þ0.10) 15 0.80 (0.
Acetabular BML
No BML 361 0.98 (0.14) 361 0.79 (0.
BML present 66 0.93 (0.12) L0.05 (L0.09, L0.01) 66 0.73 (0.
Dependent variable: BMD. Independent variable: presence or absence of BMLs. CI, conﬁd
Boldface indicates statistically signiﬁcant results (P < 0.05).
* N: numbers shown are from measurements of 198 subjects at phase 2 & phase 3 and
femoral neck BMD for one subject at phase 2 and 1 subject at phase 3 was missing.
y Data adjusted for age, sex, body mass index and ROA.Discussion
Hip BMLs were associated with local (total hip and femoral
neck) BMD, but not distant BMD (spine). Furthermore, these asso-
ciations vary according to site with femoral BMLs being associated
with higher femoral neck BMD while acetabular BMLs are associ-
ated with lower hip and femoral neck BMD. The ﬁndings were
consistent although not all were statistically signiﬁcant.
The relationship between BMD and OA has been investigated4.
Of these, only a few focus on the role of BMLs and bone density.
Population-based studies in both participants with and without OA
suggests that those with knee BMLs have higher local subchondral
BMD5,6. Further, knee BMLs are associated with increased bone
density of the compartment where they are located. It is unclear
whether this is due to BMLs having a local effect on bone or
whether they are consequences of changes in underlying bone
pathology. Demineralization of the bone under or adjacent to the
BMLs could be explained by histological studies that suggest BMLs
consist of elevated cytokines and angiogenic factors which leads to
higher bone turnover locally, hence lower BMD7,9.
At the hip, due to lack of data, the effects of BMLs on bone
density or vice versa is currently unclear. One study reports oste-
oporosis in 4/8 resected femoral heads with hip BMLs but no cor-
relation was found between this histopathological ﬁnding and hip
BMLs3, however OA bone has been found to be hypo-mineralized
with increased levels of water and organic materials10. In our
study, femoral BMLs were associated with an increase in bone
density. Longitudinally, resolving femoral BMLs were associated
with decreasing and incident femoral BMLs were associated with
increasing femoral neck BMD. Femoral BMLs would have been
located in the similar or exact region in which total hip BMD was
assessed. Conversely, acetabular BMLs that are adjacent but outside
the region used to assess BMD, were associated with lower BMD.
Cross-sectionally therewas an estimated 5e6% decrease in total hip
and femoral neck BMD. Longitudinally, bone density was higher in
subjects with resolving acetabular BMLs, while a 1% reduction in
BMD from baseline to follow-up was noted in subjects with
enlarging acetabular BMLs. These ﬁndings demonstrate opposite
associations for acetabular and femoral BMLs with BMD and should
be regarded as hypothesis generating. For instance, overall increase
in BMD and bone porosity in subjects with OA and BMLs has been
documented5,7. Additionally, femoral neck BMD in comparison to
other locations at the hip is highest in early and severe radiographic
hip OA4. It could be speculated that femoral BMLs located near the
femoral neck may increase due to an increase in femoral neck BMD
or because of changes in the subchondral bone due to increase in
bone inﬁltrates10. In contrast, acetabular BMLs that are located
away from the femoral neck and the subchondral bone associatefemoral neck and spine
D (g/cm2) Spine BMD (g/cm2)
SD) Adjusted mean
difference (95% CI)y
N* Mean (SD) Adjusted mean
difference (95% CI)y
11) 414 1.02 (0.16)
11) þ0.02 (0.06, þ0.17) 15 1.03 (0.11) <0.01 (0.08, þ0.08)
11) 363 1.03 (0.15)
08) L0.06 (L0.09,L0.03) 66 1.00 (0.15) 0.03 (0.08, þ0.01)
ence intervals.
include repeated observation on the same subjects. Moreover, data for total hip and
Table II
Longitudinal relationship between change in prevalence of hip BMLs and change in bone density of hip, femoral neck and spine
BML category N* Change in total hip BMD (g/cm2) Change in femoral neck BMD (g/cm2) Change in spine BMD (g/cm2)
Difference in mean (95% CI)y Difference in mean (95% CI)y Difference in mean (95% CI)y
Femoral BML
No BMLs 175
Resolved BML 2 0.03 (0.09, þ0.03) L0.04 (L0.09,L0.01) 0.03 (0.09, þ0.03)
Incident BML 4 þ0.02 (0.00, þ0.04) D0.03 (D0.02,D0.04) <0.01 (0.02, þ0.01)
Persistent BML 4 0.01 (0.04, þ0.01) <0.01 (0.02, þ0.03) 0.03 (0.06, 0.00)
Acetabular BML
No BML 146
Resolved BML 12 D0.02 (L0.00,D0.34) D0.01 (D0.00,D0.03) <0.01 (0.02, þ0.02)
Incident BML 10 <0.01 (0.01, þ0.23) <0.01 (0.01, þ0.02) <0.01 (0.02, þ0.01)
Persistent BML 19 <0.01 (0.02, þ0.01) <0.01 (0.02, þ0.01) 0.02 (0.04, 0.00)
Dependent variable: change in BMD. Independent variable: change in prevalence of BMLs.
Boldface indicates statistically signiﬁcant results (P < 0.05).
For these analyses, hip BMLs present at baseline and not at follow-upwere categorized as resolved BMLs. Hip BMLs present at follow-up but not at baseline were categorized as
incident BMLs. Hip BMLs present at both baseline and follow-up were categorized as persistent BMLs.
* Number of subjects in each category excluding participants with missing data at baseline or follow-up.
y Data adjusted for age, sex and body mass index.
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hip BMLs located in two different compartments might represent
bone areas undergoing different pathological changes leading to
variations in the bone density adjacent to that joint. Nevertheless,
these results might differ if we were able to measure material bone
density.
It’s unclear if BMLs are the cause or effect of secondary mech-
anisms modifying the bone. Hip BMLs, in this study, were associ-
ated with changes in local BMD perhaps, due to continuous bone
remodeling and/or bone reabsorption in bone areas with BML.
Studies have found elevated bone biochemical markers such as
bone alkaline phosphate (ALP), osteocalcin (OC), and increase in
angiogenesis factors such as vascular endothelial growth factor
(VEGF), cysteine-rich angiogenic inducer 61 (CYR61), in bone
samples with BMLs, suggesting increased bone turnover9. More-
over, BMLs may also reﬂect a paracrine effect of proinﬂammatory
cytokines such as tumor necrosis factor (TNF), interleukin-6 (IL-6),
interleukin-1 (IL-1) and leptin, which associate with pain11, carti-
lage loss12 and lower bone density in subjects with OA13,14. Lastly,
bone densitymay alter due to disuse of a painful joint mainly due to
unloading which encourages reduction in bone formation or
modeling15. Hence, both imbalances in the bone metabolism and
disuse due to pain possibly cause changes in bone that encourage
formation of BMLs.
Limitations
Bone density was measured using DXA, which provides an areal
two-dimensional BMD measure; hence our apparent BMD ﬁndings
might differ frommaterial BMD ﬁndings. As BMD can be inﬂuenced
by differences in bone size we adjusted for age, sex and BMI, which
would largely compensate for any such differences. We were un-
able to vary the region of interest for our scans thus the region of
interest where BMD was measured may include all, part or none of
the hip BMLs depending on the location of the BML which may
explain differing regional results. Longitudinal analyses were car-
ried out with only a small number of hip BMLs, however the overall
results were consistent. Hip BMLs were assessed by both presence
and cross-sectional area, which might miss very small shallow or
ﬂat BMLs. However, our areal measure has excellent performance
metrics in the knee1.
Conclusions
Hip BMLs were associated with local BMD (hip and femoral
neck) but not with spine BMD and these associations varyaccording to site. BML prevalence and change was low in this study,
hence these ﬁndings need conﬁrmation. However, we hypothesize
that these associations represent a combination of changes related
directly to the BML pathology or changes adjacent to the disease
process.
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